Follow

Submissions from 2020

Link

LGBTQIA plus health care: Faculty development and medical student education, L. Block, N. Ha, R. R. Pleak, and D. W. Rosenthal

Link

Allergy and Lung Injury Among Rescue Workers Exposed to the World Trade Center Disaster Assessed 17 Years After Exposure to Ground Zero, D. L. Caruana, P. H. Huang, J. C. Li, K. Cheslack-Postava, and A. M. Szema

Link

Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology, I. K. Chinn, A. Y. Chan, K. Chen, J. Chou, M. J. Dorsey, J. Hajjar, A. M. Jongco, M. D. Keller, L. J. Kobrynski, J. E. Walter, and +14 additional authors

Link

New York State cases of anaphylaxis in elderly patients from 2000 to 2010., C. Patel, M. Haque, O. Waqar, M. Kline, and A. Jongco

Link

New York State cases of anaphylaxis in elderly patients from 2000 to 2010, C. Patel, M. Haque, O. Waqar, M. Kline, M. Kline, and A. Jongco

Link

PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency, S. Zhang, M. Kline, R. L. Fuleihan, U. Consortium, C. Scalchunes, K. E. Sullivan, and A. M. Jongco

Submissions from 2019

Link

Secondary Hypogammaglobulinemia An Increasingly Recognized Complication of Treatment with Immunomodulators and After Solid Organ Transplantation, B. Kaplan and V. R. Bonagura

Submissions from 2018

PDF

Noninfectious manifestations and complications of chronic granulomatous disease, S. E. Henrickson, A. M. Jongco, K. F. Thomsen, E. K. Garabedian, and I. P. Thomsen

PDF

Microarray analysis of human keratinocytes from different anatomic sites reveals site-specific immune signaling and responses to human papillomavirus type 16 transfection, M. Israr, D. Rosenthal, L. Frejo-Navarro, J. DeVoti, C. Meyers, and V. R. Bonagura

PDF

Considerations in the diagnosis of chronic granulomatous disease, J. E. Yu, A. E. Azar, H. J. Chong, A. M. Jongco, and B. T. Prince

Submissions from 2015

PDF

Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus, C. Aranow, D. L. Kamen, M. Dall'Era, E. M. Massarotti, M. C. Mackay, F. Koumpouras, A. Coca, W. W. Chatham, M. E. Clowse, L. G. Criscione-Schreiber, S. Callahan, E. A. Goldmuntz, L. Keyes-Elstein, M. Oswald, P. K. Gregersen, and B. Diamond

Link

A Note from the Editor-in-Chief, Deputy Editor, and Managing Editor, V. R. Bonagura, J. L. Casanova, and D. W. Rosenthal

PDF

Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor, E. H. Chang, B. T. Volpe, M. Mackay, C. Aranow, C. Kowal, P. Mattis, R. Berlin, S. Mader, T. S. Huerta, P. T. Huerta, B. Diamond, and +3 additional authors

Link

Predictors of Long-Term Renal Outcome in Lupus Nephritis Trials Lessons Learned from the Euro-Lupus Nephritis Cohort, M. Dall'Era, M. G. Cisternas, D. E. Smilek, L. Straub, F. A. Houssiau, R. Cervera, B. H. Rovin, and M. Mackay

Link

Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand C-11-CNS5161, V. Dhawan, W. Robeson, D. Bjelke, T. Chaly, K. Graf, M. Hellman, L. M. Zhuo, M. Mackay, and D. Eidelberg

PDF

Reply to: Nasal endoscopy to characterize sinonasal disease, A. E. Dixon, M. Castro, R. I. Cohen, L. B. Gerald, J. T. Holbrook, C. G. Irvin, S. Mohapatra, S. P. Peters, S. Rayapudi, R. A. Wise, and +1 additional author

Link

Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus, M. Mackay

PDF

Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus, M. Mackay, C. C. Tang, B. T. Volpe, C. Aranow, P. J. Mattis, R. A. Korff, B. Diamond, and D. Eidelberg

PDF

Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort, B. Parker, M. B. Urowitz, D. D. Gladman, M. Lunt, R. Donn, S. C. Bae, J. Sanchez-Guerrero, C. Aranow, M. Mackay, I. N. Bruce, and +30 additional authors

PDF

A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial, F. Tamirou, B. R. Lauwerys, M. Dall'Era, M. Mackay, B. Rovin, R. Cervera, F. A. Houssiau, D. Abramowicz, L. de Bruxelles, R. Westhovens, and +35 additional authors

Submissions from 2014

PDF

Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study, A. Askanase, M. Byron, L. Keyes-Elstein, P. Cagnoli, J. McCune, B. Diamond, D. Daikh, A. Davidson, M. Mackay, D. Wofsy, and +24 additional authors

PDF

Treatment of Lupus Nephritis With Abatacept, A. D. Askanase, M. Byron, L. L. Keyes-Elstein, P. C. Cagnoli, W. J. McCune, W. W. Chatham, A. Davidson, B. Diamond, M. Mackay, R. Winchester, and +24 additional authors

PDF

X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii, A. M. Jongco, J. D. Gough, K. Sarnataro, D. W. Rosenthal, J. Moreau, P. Ponda, and V. R. Bonagura

Link

Rituximab and immune deficiency: case series and review of the literature, B. Kaplan, Y. Kopyltsova, A. Khokhar, F. Lam, and V. Bonagura